Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBG in Chronic Diabetic Foot Ulcers
NCT00632008Phase 3Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- Mar 2007
- Primary completion
- Aug 2009
- Modality
- Biologic, Polysaccharide
- Countries
- 1
01
Overview
A Phase 3 trial of Imprime PGG in diabetic foot ulcer (DFU), sponsored by Biotec Pharmacon ASA. Started Mar 2007; status: completed.
02
Drugs
Imprime PGG
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00632008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632008.